--- title: Buy Tivicay (Dolutegravir) 50mg Tabs Online description: Tivicay (Dolutegravir) 50mg Tabs is a modern antiviral for HIV-1 infection management. Secure online ordering with verified quality and delivery. type: product language: en url: https://medsforsale.net/buy-tivicay-online-en availability: in_stock price_min: 137.56 price_max: 385.99 currency: USD offers: - name: 50mg x 30 tabs price: 137.56 - name: 50mg x 60 tabs price: 220.13 - name: 50mg x 90 tabs price: 296.99 - name: 50mg x 120 tabs price: 385.99 --- # Buy Tivicay (Dolutegravir) 50mg Tabs Online Tivicay is an integrase inhibitor containing Dolutegravir, developed by ViiV Healthcare for the treatment of HIV-1 infection. It works by blocking the virus from entering host cells, thereby reducing the viral load in the body and supporting the immune system. This medication is essential for adults as part of a comprehensive antiretroviral therapy regimen. You can rely on our online pharmacy to provide Tivicay in 50mg tabs with secure and discreet shipping. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **50mg** | 30 tabs | **$137.56** | $4.59 | In Stock | | **50mg** | 60 tabs | **$220.13** | $3.67 | In Stock | | **50mg** | 90 tabs | **$296.99** | $3.30 | In Stock | | **50mg** | 120 tabs | **$385.99** | $3.22 | In Stock | [Buy Now](https://medsforsale.net/buy-tivicay-online-en) ## Introduction Tivicay (dolutegravir) is an antiretroviral medication approved for the treatment of HIV-1 infection in adults and adolescents when used as part of a combination regimen. Manufactured by ViiV Healthcare, each tablet contains 50 mg of dolutegravir, an integrase strand-transfer inhibitor (INSTI). The drug lowers the amount of virus in the blood (viral load) and helps restore immune function. In addition to its principal indication, clinicians sometimes consider dolutegravir for off-label situations such as prevention of HIV transmission or use in special populations, but these applications have not received formal regulatory approval. ## What is Tivicay? Tivicay is a tablet formulation that delivers the active compound dolutegravir. It belongs to the class of integrase strand-transfer inhibitors, which target a viral enzyme essential for HIV replication. Dolutegravir was developed by ViiV Healthcare and received FDA approval in 2013. While Tivicay is the branded product, the same molecule is available as a generic and is also incorporated into fixed-dose combinations marketed under brand names such as Triumeq, Dovato, and Juluca. ## How Tivicay Works Dolutegravir blocks the HIV integrase enzyme, preventing the integration of viral DNA into the host cell’s genome. By halting this step, the virus cannot establish a permanent infection of the cell, which curtails the production of new viral particles. The effect begins shortly after the first dose, and steady-state concentrations are typically reached within 5 days of daily dosing. Dolutegravir is primarily eliminated by metabolism through uridine-diphosphate glucuronosyltransferase (UGT) 1A1 and, to a lesser extent, by the cytochrome P450 system (CYP3A4). This metabolic profile contributes to a low potential for drug-drug interactions and supports once-daily administration. ## Conditions Treated with Tivicay - **HIV-1 infection (adults and adolescents ≥12 years)** - Tivicay is indicated as part of a complete antiretroviral regimen for patients who have no known resistance to integrase inhibitors. By suppressing viral replication, it reduces viral load, increases CD4-cell counts, and lowers the risk of disease progression. - **Fixed-dose combination therapy** - When combined with other agents (e.g., abacavir/lamivudine in Triumeq or lamivudine/tenofovir in Dovato), dolutegravir provides a single-pill regimen that simplifies adherence while maintaining high efficacy. The drug’s potency against a broad range of HIV-1 strains, together with a high genetic barrier to resistance, underlies its effectiveness in these approved settings. ## Off-Label and Investigational Uses of Tivicay - **Pre-exposure prophylaxis (PrEP)** - Small pilot studies have examined dolutegravir taken daily or on-demand as an alternative to tenofovir-based PrEP. Although viral suppression was observed in some participants, regulatory agencies have not approved this indication, and safety in large, diverse cohorts remains uncertain. - **HIV-2 infection** - Limited clinical data suggest dolutegravir retains activity against HIV-2, a less common virus variant. Use in this setting is off-label and should be guided by resistance testing and specialist input. - **Pregnant women** - Observational registries have reported that dolutegravir exposure during pregnancy does not increase major congenital anomalies, yet the FDA classifies it as a pregnancy-category B drug. It is sometimes prescribed when the benefits outweigh potential risks. - **Children younger than 12 years** - Dose-finding studies are ongoing; some clinicians prescribe dolutegravir on a weight-based schedule under specialist supervision, but this practice is not yet formally approved. All off-label applications must be discussed with a qualified healthcare provider who can weigh the limited evidence against individual clinical circumstances. ## Is Tivicay the Right Medication for You? Tivicay is most appropriate for patients who: - Have confirmed HIV-1 infection without documented resistance to integrase inhibitors. - Require a once-daily regimen that can be combined with other antiretrovirals in a single pill. - Have adequate renal function (creatinine clearance ≥ 30 mL/min) and no severe hepatic impairment. Contraindications and cautions include: - Known hypersensitivity to dolutegravir or any tablet excipient. - Use of antacids or mineral supplements containing calcium, magnesium, or iron within 2 hours of dosing (these can reduce absorption). - Co-administration with strong UGT1A1 inducers such as rifampin, which may necessitate dose adjustment. Patients with a history of severe psychiatric illness should be monitored, as rare cases of depression and suicidal thoughts have been reported. ## Risks, Side Effects, and Interactions ### Common - Headache - Insomnia or abnormal dreams - Nausea, abdominal pain, or diarrhea - Fatigue ### Rare - Weight gain (particularly in combination regimens) - Elevated serum creatinine without true renal impairment (due to inhibition of tubular secretion) - Mild increases in liver transaminases ### Serious - Severe allergic reactions (e.g., rash, angioedema, anaphylaxis) - Hepatotoxicity (rare but possible, especially with pre-existing liver disease) - Neuropsychiatric events, including depression, anxiety, or suicidal ideation - Immune reconstitution inflammatory syndrome (IRIS) after rapid viral suppression ### Drug-Drug and Drug-Food Interactions - **Metal cations** (calcium, magnesium, iron, aluminum, zinc) - bind dolutegravir in the gut; separate administration by at least 2 hours. - **Rifampin** - strong UGT1A1 inducer; recommended dolutegravir dose increase to 50 mg twice daily. - **Metformin** - dolutegravir can increase metformin plasma concentrations; monitor for lactic acidosis. - **St. John’s wort** - induces CYP3A4 and may lower dolutegravir levels; avoid concomitant use. - **Alcohol** - no direct pharmacokinetic interaction, but excessive intake can worsen hepatotoxic potential. Patients should inform their healthcare team of all prescribed, over-the-counter, and herbal products. ## Use: Dosing, Missed Dose, Overdose - **Standard dose**: One 50 mg tablet taken orally once daily, with or without food. - **Missed dose**: Take the forgotten dose as soon as remembered unless it is within 12 hours of the next scheduled dose; in that case, skip the missed tablet and continue with the regular schedule. Do not double-dose. - **Overdose**: Signs may include nausea, vomiting, or dizziness. No specific antidote exists; symptomatic and supportive care is recommended. Seek emergency medical attention if severe symptoms develop. **Practical precautions**: - Avoid taking dolutegravir together with antacids or mineral supplements; separate by at least 2 hours. - Alcohol consumption should be moderate; heavy use can exacerbate liver toxicity. - Operating heavy machinery is generally safe, but patients experiencing dizziness or severe insomnia should exercise caution. ## FAQ - **What should I know about storing Tivicay tablets?** Tivicay tablets should be kept at controlled room temperature (15-30 °C/59-86 °F), protected from excess humidity and direct sunlight. Do not refrigerate or freeze the medication. - **Can I travel internationally with Tivicay?** Yes. Carry the tablets in their original packaging with a copy of the prescription (or a letter from a licensed prescriber) to satisfy customs regulations. Keep the medication in carry-on luggage to avoid temperature extremes in checked baggage. - **Does dolutegravir affect birth-control pills?** Dolutegravir does not significantly affect hormonal contraceptives. However, patients should maintain regular contraceptive use, as the medication does not protect against pregnancy. - **What does the tablet look like?** The 50 mg Tivicay tablet is round, white, and debossed with “ViiV” on one side and “50 mg” on the other. Inert ingredients include lactose monohydrate, microcrystalline cellulose, and magnesium stearate. - **Will dolutegravir show up on a drug test?** Standard employment drug screens do not test for dolutegravir, as it is not a controlled substance. Specialized testing would be required to detect its presence. - **Is there a risk of weight gain when using Tivicay?** Modest weight gain has been observed in some patients, especially when dolutegravir is combined with tenofovir alafenamide. The effect is generally modest and should be balanced against the benefits of viral suppression. - **How long does it take for Tivicay to lower viral load?** A measurable decline in HIV-1 RNA is usually seen within 2 weeks of initiating therapy, with most patients achieving undetectable levels (<50 copies/mL) by 12 weeks when adherence is optimal. - **Can I take Tivicay with a high-calcium diet?** Calcium-rich foods do not interfere with dolutegravir absorption. Only calcium supplements or antacids containing calcium need to be spaced apart from the dose. - **What is the difference between Tivicay and generic dolutegravir?** Both contain the same active ingredient and are bioequivalent. The generic version is typically less expensive and may be sourced from licensed overseas pharmacies, while Tivicay is the brand product manufactured by ViiV Healthcare. - **Are there special considerations for patients with kidney disease?** No dosage adjustment is required for mild to moderate renal impairment. In severe renal dysfunction (creatinine clearance < 30 mL/min), dolutegravir is still used, but clinicians monitor serum creatinine and dosing of concomitant renally cleared drugs. - **Why is dolutegravir sometimes stopped during pregnancy?** Some clinicians temporarily discontinue dolutegravir in the third trimester due to early concerns about neural-tube defects, although later data have not confirmed a strong link. Current guidelines allow continuation if the benefits outweigh potential risks. - **How does resistance testing influence the use of Tivicay?** Baseline genotypic resistance testing for the integrase gene helps identify mutations that could compromise dolutegravir efficacy. If major resistance-associated mutations are present, alternative regimens are recommended. ## Glossary **Integrase Strand-Transfer Inhibitor (INSTI)** : A class of antiretroviral drugs that block the HIV integrase enzyme, preventing viral DNA from integrating into host DNA. **Viral Load** : The quantity of HIV RNA copies per milliliter of blood; a primary marker used to assess treatment effectiveness. **Resistance Mutation** : A change in the viral genome that reduces susceptibility to a specific drug, potentially leading to treatment failure. **Hepatic Transaminases** : Enzymes (ALT, AST) measured in blood to evaluate liver health; elevations can signal drug-induced liver injury. ## Buying Tivicay from [our online pharmacy](https://medsforsale.net/buy-tivicay-online-en) Patients who encounter cost barriers or limited local availability can obtain Tivicay through **[our online pharmacy](https://medsforsale.net/buy-tivicay-online-en)**. We source the medication from licensed, vetted suppliers who meet stringent quality-assurance standards, ensuring the product matches the manufacturer’s specifications. By operating as a pharmacy-broker service, we offer a cost-effective alternative that approaches manufacturer pricing while maintaining full regulatory compliance. Key advantages include: - **Affordability** - Lower acquisition costs compared with many retail pharmacies, helping patients stay on therapy without financial strain. - **Verified Quality** - Every batch is inspected for authenticity and potency before shipment. - **Discreet Delivery** - Packages are shipped in unmarked, secure envelopes, with options for express (≈ 7 days) or standard airmail (≈ 3 weeks) to meet diverse timelines. - **Privacy-Focused Service** - Our process respects patient confidentiality; personal data is handled in accordance with data-protection regulations. For individuals who lack insurance coverage, reside in regions with restricted drug formularies, or simply prefer a reliable online channel, **[our online pharmacy](https://medsforsale.net/buy-tivicay-online-en)** provides a trustworthy means to access Tivicay. ## Disclaimer The information presented here about Tivicay is intended for general educational purposes and does not substitute professional medical advice. Treatment choices, including any off-label applications, should be made only under the direct supervision of a qualified healthcare professional. Readers are presumed to be responsible adults capable of making informed health decisions. **[our online pharmacy](https://medsforsale.net/buy-tivicay-online-en)** supplies Tivicay for persons who may encounter limited access through conventional pharmacies or insurance plans, or who seek a cost-effective generic alternative. Always consult a healthcare provider before initiating, altering, or stopping any medication.